Ling‐Yu Chu

403 total citations
30 papers, 220 citations indexed

About

Ling‐Yu Chu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ling‐Yu Chu has authored 30 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 12 papers in Pulmonary and Respiratory Medicine and 11 papers in Oncology. Recurrent topics in Ling‐Yu Chu's work include Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (11 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). Ling‐Yu Chu is often cited by papers focused on Esophageal Cancer Research and Treatment (12 papers), Gastric Cancer Management and Outcomes (11 papers) and Inflammatory Biomarkers in Disease Prognosis (5 papers). Ling‐Yu Chu collaborates with scholars based in China and India. Ling‐Yu Chu's co-authors include Yi‐Wei Xu, Yu‐Hui Peng, Jian‐Jun Xie, Chao‐Qun Hong, Yi‐Wei Lin, Xinyi Huang, Haipeng Guo, Dongming Guo, Yiteng Huang and Feiran Zhang and has published in prestigious journals such as Scientific Reports, The Journal of Pathology and World Journal of Gastroenterology.

In The Last Decade

Ling‐Yu Chu

27 papers receiving 220 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ling‐Yu Chu 92 85 75 65 64 30 220
In Gu 58 0.6× 64 0.8× 72 1.0× 50 0.8× 33 0.5× 15 204
Shanghua Jing 128 1.4× 57 0.7× 25 0.3× 44 0.7× 86 1.3× 23 214
Yanan Xu 118 1.3× 56 0.7× 75 1.0× 28 0.4× 86 1.3× 14 287
Dongliang Bian 66 0.7× 135 1.6× 44 0.6× 98 1.5× 27 0.4× 28 290
Giandomenico Di Menna 36 0.4× 167 2.0× 23 0.3× 40 0.6× 47 0.7× 24 233
Meifang Xu 97 1.1× 129 1.5× 55 0.7× 43 0.7× 77 1.2× 30 286
Qiuyan Xu 108 1.2× 65 0.8× 47 0.6× 66 1.0× 62 1.0× 24 269
Shunfang Yang 222 2.4× 85 1.0× 51 0.7× 91 1.4× 105 1.6× 9 341
Cristina Pizzimenti 44 0.5× 57 0.7× 31 0.4× 31 0.5× 19 0.3× 41 182
Stephanie Eng 83 0.9× 54 0.6× 71 0.9× 34 0.5× 23 0.4× 5 240

Countries citing papers authored by Ling‐Yu Chu

Since Specialization
Citations

This map shows the geographic impact of Ling‐Yu Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling‐Yu Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling‐Yu Chu more than expected).

Fields of papers citing papers by Ling‐Yu Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling‐Yu Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling‐Yu Chu. The network helps show where Ling‐Yu Chu may publish in the future.

Co-authorship network of co-authors of Ling‐Yu Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Ling‐Yu Chu. A scholar is included among the top collaborators of Ling‐Yu Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling‐Yu Chu. Ling‐Yu Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chu, Ling‐Yu, Haipeng Guo, Jian‐Jun Xie, et al.. (2024). Combined detection of serum EFNA1 and MMP13 as diagnostic biomarker for gastric cancer. Scientific Reports. 14(1). 15957–15957. 5 indexed citations
3.
Chu, Ling‐Yu, Wang‐Kai Fang, Chao‐Qun Hong, et al.. (2023). Secreted proteins encoded by super enhancer-driven genes could be promising biomarkers for early detection of esophageal squamous cell carcinoma. Biomedical Journal. 47(4). 100662–100662. 2 indexed citations
4.
Lin, Yi‐Wei, Chao‐Qun Hong, Zihan Qiu, et al.. (2023). Nutritional and immune-related indicators-based Nomogram for predicting overall survival of surgical oral tongue squamous cell carcinoma. Scientific Reports. 13(1). 8525–8525. 4 indexed citations
5.
7.
Chu, Ling‐Yu, et al.. (2022). EFNA1in gastrointestinal cancer: Expression, regulation and clinical significance. World Journal of Gastrointestinal Oncology. 14(5). 973–988. 5 indexed citations
8.
Peng, Yu‐Hui, Chao‐Qun Hong, Ling‐Yu Chu, et al.. (2022). Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinoma. Discover Oncology. 13(1). 128–128. 4 indexed citations
9.
Chu, Ling‐Yu, Jianyuan Zhou, Yixuan Zhao, et al.. (2021). Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor. Bioscience Reports. 41(6). 2 indexed citations
10.
Chu, Ling‐Yu, Yi‐Wei Lin, Yun Luo, et al.. (2021). A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery. Cancer Management and Research. Volume 13. 7771–7782. 8 indexed citations
11.
12.
Lin, Yi‐Wei, Zihan Qiu, Biao Zhang, et al.. (2021). Nomogram based on clinical characteristics and serological inflammation markers to predict overall survival of oral tongue squamous cell carcinoma patient after surgery. BMC Oral Health. 21(1). 667–667. 13 indexed citations
13.
Zhou, Jianyuan, Min Yang, Ling‐Yu Chu, et al.. (2020). CATA: a comprehensive chromatin accessibility database for cancer. Database. 2022. 1 indexed citations
14.
Qiu, Bo, et al.. (2020). <p>Diagnostic Value of Serum Insulin-Like Growth Factor Binding Protein 7 (IGFBP7) in Colorectal Cancer</p>. OncoTargets and Therapy. Volume 13. 12131–12139. 3 indexed citations
15.
Chen, Hao, Chao‐Qun Hong, Ling‐Yu Chu, et al.. (2020). Nomogram based on nutritional and inflammatory indicators for survival prediction of small cell carcinoma of the esophagus. Nutrition. 84. 111086–111086. 8 indexed citations
16.
Xu, Yi‐Wei, Hao Chen, Chao‐Qun Hong, et al.. (2020). Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour. EBioMedicine. 51. 102566–102566. 19 indexed citations
17.
Chu, Ling‐Yu, et al.. (2020). Blood-based biomarkers for early detection of esophageal squamous cell carcinoma. World Journal of Gastroenterology. 26(15). 1708–1725. 53 indexed citations
18.
Xu, Yi‐Wei, Hong Guo, Chao‐Qun Hong, et al.. (2019). Serum Insulin-Like Growth Factor Binding Protein 7 as a Potential Biomarker in the Diagnosis and Prognosis of Esophagogastric Junction Adenocarcinoma. Gut and Liver. 14(6). 727–734. 6 indexed citations
19.
Huang, Xinyi, Chao‐Qun Hong, Yu‐Hui Peng, et al.. (2019). The Diagnostic Value of Serum IGFBP7 in Patients with Esophageal Squamous Cell Carcinoma. Journal of Cancer. 10(12). 2687–2693. 16 indexed citations
20.
Guo, Dongming, et al.. (2019). <p>Potential Diagnostic Value Of Combining Inflammatory Cell Ratios With Carcinoembryonic Antigen For Colorectal Cancer</p>. Cancer Management and Research. Volume 11. 9631–9640. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026